Jefferies Financial Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,400
Closed -$67.1K 1964
2024
Q1
$67.1K Buy
16,400
+4,600
+39% +$20.6K ﹤0.01% 1478
2023
Q4
$69K Hold
11,800
﹤0.01% 1572
2023
Q3
$60.8K Buy
+11,800
New +$55.4K ﹤0.01% 1497

Other funds holding AUGX

Jefferies Financial Group's AUGX Position: Q2 2024 in Review

Jefferies Financial Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 16,400 shares — an estimated $67.1K sold.

Jefferies Financial Group first reported a position in AUGX in Q3 2023 and held it in 3 quarters. The position peaked at $69K in Q4 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Jefferies Financial Group reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 16,400 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $67.1K.
  • Jefferies Financial Group first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Augmedix, Inc. Common Stock position peaked at $69K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.